AU2003231802A1 - Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies - Google Patents
Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodiesInfo
- Publication number
- AU2003231802A1 AU2003231802A1 AU2003231802A AU2003231802A AU2003231802A1 AU 2003231802 A1 AU2003231802 A1 AU 2003231802A1 AU 2003231802 A AU2003231802 A AU 2003231802A AU 2003231802 A AU2003231802 A AU 2003231802A AU 2003231802 A1 AU2003231802 A1 AU 2003231802A1
- Authority
- AU
- Australia
- Prior art keywords
- crohn
- psoriasis
- disease
- treatment
- gamma antibodies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/249—Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15074202A | 2002-05-17 | 2002-05-17 | |
US10/150,742 | 2002-05-17 | ||
US38331002P | 2002-05-22 | 2002-05-22 | |
US60/383,310 | 2002-05-22 | ||
PCT/US2003/015874 WO2003097082A2 (en) | 2002-05-17 | 2003-05-16 | Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003231802A1 true AU2003231802A1 (en) | 2003-12-02 |
Family
ID=29552737
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003231802A Abandoned AU2003231802A1 (en) | 2002-05-17 | 2003-05-16 | Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1506002A4 (ja) |
JP (1) | JP2005529152A (ja) |
AU (1) | AU2003231802A1 (ja) |
CA (1) | CA2486147A1 (ja) |
WO (1) | WO2003097082A2 (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0695189T3 (da) | 1992-12-29 | 1999-08-09 | Genentech Inc | Behandling af inflammatorisk tarmsygdom med IFN-gammainhibitorer |
CN101151277B (zh) * | 2005-01-27 | 2013-11-13 | 诺维莫尼公司 | 抗干扰素γ抗体及其使用方法 |
JP2009534428A (ja) * | 2006-04-25 | 2009-09-24 | インターツェル・アクチェンゲゼルシャフト | Hcvワクチン接種 |
RU2497545C2 (ru) * | 2008-03-18 | 2013-11-10 | Эбботт Лэборетриз | Способ лечения псориаза (варианты) |
KR20140097336A (ko) | 2011-11-23 | 2014-08-06 | 암젠 인크 | 인터페론 감마에 대한 항체를 이용한 치료 방법 |
MA41271A (fr) * | 2014-12-26 | 2017-10-31 | Celgene Alpine Invest Company Ii Llc | Méthodes d'utilisation d'oligonucléotides antisens ciblant smad7 |
EA037532B1 (ru) | 2015-05-07 | 2021-04-08 | Новиммун Са | Способы и композиции для диагностики и лечения заболеваний у пациентов, имеющих повышенные уровни cxcl9 и других биомаркеров |
US11091543B2 (en) | 2015-05-07 | 2021-08-17 | Swedish Orphan Biovitrum Ag | Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
WO1991010741A1 (en) | 1990-01-12 | 1991-07-25 | Cell Genesys, Inc. | Generation of xenogeneic antibodies |
US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
CA2124967C (en) | 1991-12-17 | 2008-04-08 | Nils Lonberg | Transgenic non-human animals capable of producing heterologous antibodies |
DK0695189T3 (da) * | 1992-12-29 | 1999-08-09 | Genentech Inc | Behandling af inflammatorisk tarmsygdom med IFN-gammainhibitorer |
CA2297692A1 (en) * | 1997-08-18 | 1999-02-25 | Innogenetics N.V. | Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disorders |
DE69942671D1 (de) | 1998-12-01 | 2010-09-23 | Facet Biotech Corp | Humanisierte antikoerper gegen gamma-interferon |
US20050019323A1 (en) * | 2002-05-22 | 2005-01-27 | Protein Design Labs, Inc. | Treatment of Crohn's disease or psoriasis using anti-interferon gamma antibodies |
-
2003
- 2003-05-16 EP EP03753102A patent/EP1506002A4/en not_active Withdrawn
- 2003-05-16 CA CA002486147A patent/CA2486147A1/en not_active Abandoned
- 2003-05-16 WO PCT/US2003/015874 patent/WO2003097082A2/en active Application Filing
- 2003-05-16 JP JP2004505078A patent/JP2005529152A/ja active Pending
- 2003-05-16 AU AU2003231802A patent/AU2003231802A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2005529152A (ja) | 2005-09-29 |
CA2486147A1 (en) | 2003-11-27 |
WO2003097082A3 (en) | 2004-12-09 |
WO2003097082A2 (en) | 2003-11-27 |
EP1506002A4 (en) | 2006-06-07 |
EP1506002A2 (en) | 2005-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1204654A1 (en) | Therapeutic human anti-il-1r1 monoclonal antibody -il-1r1 | |
WO2004030615A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
WO2004016225A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
EP1571968A3 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
WO2004045516A9 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
EP1416961A4 (en) | COMPOSITION AND METHOD FOR THE TREATMENT OF A DISEASE | |
IL159344A0 (en) | Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease | |
AU2003223579A1 (en) | Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease | |
EP1572091A3 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
WO2004060270A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
WO2003057160A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
EP1560593A4 (en) | NEW COMPOSITION AND METHOD FOR THE TREATMENT OF IMMUNE DISEASES | |
EP1542721A4 (en) | MODIFIED "S" ANTIBODIES | |
AU2002315131A1 (en) | Aminediols as agents for the treatment of alzheimer's disease | |
AU2003268295A1 (en) | "diagnosis and treatment of infertility" | |
AU2003291536A1 (en) | Method for the diagnosis and treatment of vascular disease | |
AU2003231802A1 (en) | Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies | |
AU2003303141A1 (en) | Hydroxypropyl amides for the treatment of alzheimer's disease | |
AU2003254146A1 (en) | Methods for the treatment of parkinson's disease | |
AU2003273310A1 (en) | Substituted aminoethers for the treatment of alzheimer's disease | |
AU2003248660A1 (en) | Treatment of vascular dysfunction and alzheimer's disease | |
EP1575497A4 (en) | NEW COMPOSITION AND METHOD FOR TREATING PSORIASIS | |
PL375564A1 (en) | Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma | |
AU2003284898A1 (en) | Combinative nicotinic/d1 agonism therapy for the treatment of alzheimer's disease | |
AU2003228339A1 (en) | Prevention and treatment of disease using angiogenesis-and/or tumor antigens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |